A recent review of 20 studies indicates that while explainable artificial intelligence (XAI) shows promise for detecting and characterizing Stage B heart failure, its current implementation is limited. Key issues include inconsistent adoption of XAI methods, with SHAP being the most common but often insufficient, and a lack of consideration for sex and ethnic subgroups in analyses. Furthermore, the evaluation and external validation of XAI outputs are frequently inadequate, hindering generalizability and clinical adoption. AI
IMPACT Highlights the need for more robust and equitable AI validation in medical applications.
RANK_REASON Academic paper detailing a review of AI methods for a specific medical condition. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
